EA199900965A1 - Лекарственные формы с замедленным высвобождением сертралина - Google Patents

Лекарственные формы с замедленным высвобождением сертралина

Info

Publication number
EA199900965A1
EA199900965A1 EA199900965A EA199900965A EA199900965A1 EA 199900965 A1 EA199900965 A1 EA 199900965A1 EA 199900965 A EA199900965 A EA 199900965A EA 199900965 A EA199900965 A EA 199900965A EA 199900965 A1 EA199900965 A1 EA 199900965A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dosage forms
delayed
sertralin
slow release
along
Prior art date
Application number
EA199900965A
Other languages
English (en)
Other versions
EA001906B1 (ru
Inventor
Уильям Джон Кьюратоло
Хайлар Льюис Фридман
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199900965(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900965A1 publication Critical patent/EA199900965A1/ru
Publication of EA001906B1 publication Critical patent/EA001906B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Лекарственные формы с замедленным высвобождением сертралина, которые уменьшают Ти уменьшают побочные действия. В общем, лекарственные формы представляют собой лекарственные формы с пространственным замедлением за счет того, что они чувствительны к их местоположению вдоль желудочно-кишечного тракта, или лекарственные формы с замедлением по времени за счет того, что они являются замедленными на предопределенный период независимо от их местоположения вдоль желудочно-кишечного тракта. Представлены тесты in vitro для идентификации таких лекарственных форм.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900965A 1997-07-01 1998-06-16 Лекарственные формы с замедленным высвобождением сертралина EA001906B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en) 1997-07-01 1998-06-16 Delayed-release dosage forms of sertraline

Publications (2)

Publication Number Publication Date
EA199900965A1 true EA199900965A1 (ru) 2000-08-28
EA001906B1 EA001906B1 (ru) 2001-10-22

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900965A EA001906B1 (ru) 1997-07-01 1998-06-16 Лекарственные формы с замедленным высвобождением сертралина

Country Status (41)

Country Link
EP (1) EP1007024B1 (ru)
JP (1) JP3786715B2 (ru)
KR (1) KR100369698B1 (ru)
CN (4) CN1151783C (ru)
AP (1) AP1199A (ru)
AR (1) AR038394A2 (ru)
AT (1) ATE245415T1 (ru)
AU (1) AU727152B2 (ru)
BG (1) BG64742B1 (ru)
BR (1) BR9809895A (ru)
CA (1) CA2290969C (ru)
DE (1) DE69816624T2 (ru)
DK (1) DK1007024T3 (ru)
DZ (1) DZ2547A1 (ru)
EA (1) EA001906B1 (ru)
ES (1) ES2202858T3 (ru)
GT (1) GT199800091A (ru)
HK (1) HK1027982A1 (ru)
HN (1) HN1998000099A (ru)
HR (1) HRP980376B1 (ru)
HU (1) HUP0301787A3 (ru)
ID (1) ID23187A (ru)
IL (2) IL133081A (ru)
IS (1) IS5267A (ru)
MA (1) MA24585A1 (ru)
NO (1) NO996519L (ru)
NZ (1) NZ501249A (ru)
OA (1) OA11247A (ru)
PA (1) PA8454201A1 (ru)
PE (1) PE84399A1 (ru)
PL (1) PL337799A1 (ru)
PT (1) PT1007024E (ru)
SI (1) SI1007024T1 (ru)
SK (1) SK173299A3 (ru)
TN (1) TNSN98122A1 (ru)
TR (1) TR199903295T2 (ru)
TW (1) TW575437B (ru)
UA (1) UA63953C2 (ru)
UY (1) UY25068A1 (ru)
WO (1) WO1999001122A1 (ru)
ZA (1) ZA985710B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
RU2275191C2 (ru) * 1999-05-20 2006-04-27 Элан Корпорейшн, Плс Состоящие из множества частиц фармацевтические составы с контролируемым высвобождением избирательного ингибитора повторного поглощения серотонина
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
HU230402B1 (hu) * 2000-02-10 2016-04-28 Evonik Röhm Gmbh Bélben oldódó akril bevonó készítmények
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
RU2324475C2 (ru) * 2001-04-10 2008-05-20 Сан Фармасьютикал Индастриз Лимитед Состав, выделяемый в импульсном режиме в заданное время
CA2457385A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
SI1007024T1 (en) 2003-12-31
KR20010013522A (ko) 2001-02-26
AP9801278A0 (en) 1998-06-30
EA001906B1 (ru) 2001-10-22
UA63953C2 (ru) 2004-02-16
HN1998000099A (es) 1998-10-22
UY25068A1 (es) 2000-12-29
BG103916A (en) 2000-07-31
CN1475208A (zh) 2004-02-18
AU7545198A (en) 1999-01-25
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
EP1007024B1 (en) 2003-07-23
IL133081A (en) 2005-09-25
CN1494899A (zh) 2004-05-12
TW575437B (en) 2004-02-11
AP1199A (en) 2003-08-28
IL133081A0 (en) 2001-03-19
EP1007024A1 (en) 2000-06-14
ID23187A (id) 2000-03-23
CA2290969C (en) 2004-02-17
HUP0301787A3 (en) 2005-04-28
IS5267A (is) 1999-11-23
DE69816624D1 (de) 2003-08-28
NO996519D0 (no) 1999-12-28
ATE245415T1 (de) 2003-08-15
OA11247A (en) 2002-11-19
MA24585A1 (fr) 1998-12-31
JP2000513751A (ja) 2000-10-17
CA2290969A1 (en) 1999-01-14
ZA985710B (en) 2000-01-10
PL337799A1 (en) 2000-09-11
DZ2547A1 (fr) 2003-02-08
PT1007024E (pt) 2003-11-28
CN1261273A (zh) 2000-07-26
BG64742B1 (bg) 2006-02-28
HRP980376A2 (en) 1999-04-30
NO996519L (no) 2000-02-29
KR100369698B1 (ko) 2003-01-30
CN1475209A (zh) 2004-02-18
HRP980376B1 (en) 2002-12-31
CN1151783C (zh) 2004-06-02
DK1007024T3 (da) 2003-11-17
WO1999001122A1 (en) 1999-01-14
HUP0301787A2 (hu) 2003-11-28
AU727152B2 (en) 2000-12-07
SK173299A3 (en) 2000-11-07
TR199903295T2 (xx) 2000-08-21
AR038394A2 (es) 2005-01-12
PA8454201A1 (es) 2000-09-29
JP3786715B2 (ja) 2006-06-14
DE69816624T2 (de) 2004-02-19
NZ501249A (en) 2001-06-29
HK1027982A1 (en) 2001-02-02
PE84399A1 (es) 1999-09-11
ES2202858T3 (es) 2004-04-01
TNSN98122A1 (fr) 2005-03-15
BR9809895A (pt) 2000-08-01

Similar Documents

Publication Publication Date Title
EA199900965A1 (ru) Лекарственные формы с замедленным высвобождением сертралина
DE60037203D1 (de) Medikamentenspender
DE60115698D1 (de) Medikamentenspender
EE200100525A (et) Adamantaani derivaadid
EE200200330A (et) Adamantaani derivaadid
IS6405A (is) Adamantanafleiður
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
BR0112519A (pt) Derivados anticonvulsivantes úteis para prevenir o desenvolvimento de diabetes melito do tipo ii e sìndrome x
PT1109812E (pt) Pirrolobenzodiazepinas
DE60023211D1 (de) Materialprüfung
NL1009331A1 (nl) Genonyleerde difenylaminen.
DE50000494D1 (de) Funktionsträgeranordnung
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
DE59802126D1 (de) Tablettentestgerät
DE60136367D1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger
DE10085328T1 (de) Lampenpräsentationssystem
SV2004000087A (es) Amidas de acidos fenilciclohexanocarboxilicos sustituidos ref. lea 33469-sv
UA3094S (uk) Костюм польовий для військовослужбовців
TH88188A (th) สารสูตรผสมเชิงเภสัชกรรมชนิดปลดปล่อยทันที
HN1998000103A (es) Sales de sertralina y formas de dosificacion de liberacion sostenida de sertralina
KR970025637U (ko) 프리트 픽스쳐 이송장치
TH70175A (ru)
ES1042896Y (es) Dispositivo para la exposicion multiple de carteles.
UA3371S (uk) Брюки вовняні для військовослужбовців
DK1347760T3 (da) Farmaceutiske kompositioner med NMDA receptor agonister